Products - Hikma
WEBWe provide patients across our markets with 760+ high-quality and affordable medicines. We manufacture and bring patients across North America, MENA and Europe a broad range of injectable and oral generics, branded generics, specialty and branded pharmaceutical and compounded products.
Products | Hikma
WEBOur products in the US. This page is intended for US audiences only. We provide injectable, non-injectable and specialty products.
Hikma
WEBAug 8, 2024 · Together we are building a leading generics and specialty pharmaceutical company where everyone can thrive. Learn more about our strategy, investment case and track record of success.
Hikma Pharmaceuticals - Wikipedia
WEBHikma Pharmaceuticals plc is a British multinational pharmaceutical company with headquarters in London, UK that manufactures non-branded generic and in-licensed pharmaceutical products. It was founded by Samih Darwazah in Amman, Jordan in 1978.
Browse our Products - Hikma
WEB• To report an adverse event or product complaint, please contact us at us.hikma@primevigilance.com or call 1-877-845-0689 or 1-800-962-8364. • Adverse events may also be reported to the FDA directly at 1-800-FDA-1088 or www.fda.gov/medwatch .
Hikma Pharmaceuticals USA Inc. Products: Prescription …
WEBJan 30, 2024 · For adjunctive treatment of: edema due to congestive heart failure; drug-induced edema; centrencephalic epilepsies (petit mal, unlocalized seizures); chronic simple (open-angle) glaucoma,…. Hikma Pharmaceuticals USA Inc. 11 April 2024.
Hikma Pharmaceuticals USA Inc. Company Information - Drugs.com
WEBHikma Pharmaceuticals USA Inc. manufactures, markets and/or distributes more than 185 drugs in the United States. Medications listed here may also be marketed under different names in different countries.
Amarin v. Hikma: Defining the limits of protection that skinny …
WEB3 days ago · Amarin Pharma, Inc. v. Hikma Pharmaceuticals USA Inc., No. 2023-1169 (Fed. Cir. 2024). The Amarin decision is the Federal Circuit’s latest attempt to grapple with the issue of skinny labels, and it explores the interplay between a generic’s reliance on a skinny label, and liability for induced patent infringement. How “skinny labels” work.
HKMPF Hikma Pharmaceuticals PLC - Seeking Alpha
WEBSep 15, 2024 · Hikma Pharmaceuticals PLC develops, manufactures, markets, and sells a range of generic, branded, and in-licensed pharmaceutical products. It operates through three segments: Injectables,...
Hikma completes Xellia acquisition | Drug Store News
WEB9/12/2024. Supports the long-term growth of Hikma’s Injectables business. Diversifies and enriches Hikma’s U.S. injectables portfolio and pipeline. Expands Hikma’s high-quality manufacturing ...
Skip to content